HIV Drug Based in Research by Sundquist Lab is Science’s 2024 Breakthrough of the Year
Lenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreLenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MorePreventing the protein’s activity causes parasites to die unusually rapidly.
Read More